title: 5-FU schedules, serum 5-FU levels and their relationship to therapy response and toxicity in patients with gastrointestinal cancer.
authors.affiliation: Department of Gastroenterology and Endocrinology, University Medicine Göttingen, Göttingen, Germany.
authors.forename: Martina
authors.initials: M
authors.lastname: Blaschke
authors.forename: Silke
authors.initials: S
authors.lastname: Cameron
authors.forename: Colin
authors.initials: C
authors.lastname: Goeschen
authors.forename: Giuliano
authors.initials: G
authors.lastname: Ramadori
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000097:blood* / Q000627:therapeutic use*; D019540:Area Under Curve; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005472:Fluorouracil / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood*; D005770:Gastrointestinal Neoplasms / Q000097:blood* / Q000188:drug therapy*; D006801:Humans; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil